ValiRx - Extension of Collaboration Agreement
VAL Mon, 15 Feb 2021, 12:00pm GMT
ValiRx Plc is a life science company, which focuses on clinical stage cancer therapeutic development, taking proprietary & novel technology for precision medicines towards commercialisation and partnering
Industry: Health Care
Dr Suzy Dilly, Chief Executive Officer, discusses the recently announced agreement with Physiomics plc. ValiRx is pleased to be able to expand their collaboration and the scope of work being carried out by Physiomics.